发明名称 Nitrosated and nitrosylated h2 receptor antagonist compounds, compositions and methods of use
摘要 The invention describes novel nitrosated and/or nitrosylated H<SUB>2 </SUB>receptor antagonist compounds, and novel compositions comprising at least one H<SUB>2 </SUB>receptor antagonist compound that is optionally substituted with at least one NO and/or NO<SUB>2 </SUB>group, and, optionally, at least one compound that donates, transfers or releases nitric oxide, stimulates endogenous synthesis of nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor or is a substrate for nitric oxide synthase and/or at least one nonsteroidal antiinflammatory drug, antacid, bismuth-containing reagent or anti-viral agent. The invention also describes methods for treating and/or preventing gastrointestinal disorders; improving gastroprotective properties of H<SUB>2 </SUB>receptor antagonists; decreasing the recurrence of ulcers; facilitating ulcer healing; preventing and/or treating inflammations and microbial infections, ophthalmic diseases and disorders, multiple sclerosis, and viral infections; and decreasing or reducing the gastrointestinal toxicity associated with the use of nonsteroidal antiinflammatory compounds.
申请公布号 AU1915200(A) 申请公布日期 2000.06.05
申请号 AU20000019152 申请日期 1999.11.17
申请人 NITROMED, INC. 发明人 DAVID S GARVEY;L. GORDON LETTS;TIANSHENG WANG
分类号 C07D295/08;A61K31/198;A61K31/222;A61K31/29;A61K31/341;A61K31/397;A61K31/40;A61K31/401;A61K31/4164;A61K31/426;A61K31/445;A61K31/4453;A61K31/55;A61K45/06;A61P1/04;A61P17/00;A61P27/02;A61P27/06;A61P27/16;A61P29/00;A61P31/00;A61P31/04;A61P31/18;C07D233/54;C07D233/64;C07D277/28;C07D277/48;C07D277/52;C07D295/096;C07D307/52 主分类号 C07D295/08
代理机构 代理人
主权项
地址